Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis

Hatsumi Taniguchi, Hironori Aramaki, Yoshihiko Nikaido, Yasuo Mizuguchi, Masahiro Nakamura, Toshihiko Koga, Shin Ichi Yoshida

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Using 39 clinical isolates of Mycobacterium tuberculosis strains with a broad range of susceptibility to rifampicin, we examined the relationship between the degree of resistance to rifampicin and mutational sites of the rpoB gene. All rifampicin-resistant strains had missense mutations. Twenty strains (95%) had a mutation in the cluster I region, which has also been reported in Escherichia coli [Jin and Gross (1988) J. Mol. Biol. 202, 45-58], and the remaining one strain had a mutation at codon 381 [Ala → Val] in the N-terminal region, which has not been reported in E. coli. Among 18 rifampicin-susceptible strains, two had a mutation in the cluster I region and the other three strains had a mutation in the cluster III region. The mutations at codons 513 (5%), 526 (33%) or 531 (43%) in the cluster I region led to high level resistance to rifampicin (50 μg ml-1 ≤ MIC). The mutations at the other sites, in the cluster III region (codons 679 or 687) and even in the cluster I region (codon 514, 521, or 533), showed low level (MIC = 12.5 μg ml-1) or no (MIC < 0.39 μg ml-1) resistance to rifampicin. These results suggest that mutations in the rpoB gene are, mostly, but not necessarily, associated with rifampicin resistance of M. tuberculosis, and the sites of mutations on the rpoB gene will affect the level of resistance to rifampicin.

Original languageEnglish
Pages (from-to)103-108
Number of pages6
JournalFEMS microbiology letters
Volume144
Issue number1
DOIs
Publication statusPublished - Oct 15 1996
Externally publishedYes

Fingerprint

Rifampin
Mycobacterium tuberculosis
Mutation
Codon
Genes
Escherichia coli
Missense Mutation

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Molecular Biology
  • Genetics

Cite this

Taniguchi, H., Aramaki, H., Nikaido, Y., Mizuguchi, Y., Nakamura, M., Koga, T., & Yoshida, S. I. (1996). Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS microbiology letters, 144(1), 103-108. https://doi.org/10.1016/0378-1097(96)00346-1

Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. / Taniguchi, Hatsumi; Aramaki, Hironori; Nikaido, Yoshihiko; Mizuguchi, Yasuo; Nakamura, Masahiro; Koga, Toshihiko; Yoshida, Shin Ichi.

In: FEMS microbiology letters, Vol. 144, No. 1, 15.10.1996, p. 103-108.

Research output: Contribution to journalArticle

Taniguchi, H, Aramaki, H, Nikaido, Y, Mizuguchi, Y, Nakamura, M, Koga, T & Yoshida, SI 1996, 'Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis', FEMS microbiology letters, vol. 144, no. 1, pp. 103-108. https://doi.org/10.1016/0378-1097(96)00346-1
Taniguchi, Hatsumi ; Aramaki, Hironori ; Nikaido, Yoshihiko ; Mizuguchi, Yasuo ; Nakamura, Masahiro ; Koga, Toshihiko ; Yoshida, Shin Ichi. / Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. In: FEMS microbiology letters. 1996 ; Vol. 144, No. 1. pp. 103-108.
@article{2f0feb945ffa43808b9da0fa05f8e8a5,
title = "Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis",
abstract = "Using 39 clinical isolates of Mycobacterium tuberculosis strains with a broad range of susceptibility to rifampicin, we examined the relationship between the degree of resistance to rifampicin and mutational sites of the rpoB gene. All rifampicin-resistant strains had missense mutations. Twenty strains (95{\%}) had a mutation in the cluster I region, which has also been reported in Escherichia coli [Jin and Gross (1988) J. Mol. Biol. 202, 45-58], and the remaining one strain had a mutation at codon 381 [Ala → Val] in the N-terminal region, which has not been reported in E. coli. Among 18 rifampicin-susceptible strains, two had a mutation in the cluster I region and the other three strains had a mutation in the cluster III region. The mutations at codons 513 (5{\%}), 526 (33{\%}) or 531 (43{\%}) in the cluster I region led to high level resistance to rifampicin (50 μg ml-1 ≤ MIC). The mutations at the other sites, in the cluster III region (codons 679 or 687) and even in the cluster I region (codon 514, 521, or 533), showed low level (MIC = 12.5 μg ml-1) or no (MIC < 0.39 μg ml-1) resistance to rifampicin. These results suggest that mutations in the rpoB gene are, mostly, but not necessarily, associated with rifampicin resistance of M. tuberculosis, and the sites of mutations on the rpoB gene will affect the level of resistance to rifampicin.",
author = "Hatsumi Taniguchi and Hironori Aramaki and Yoshihiko Nikaido and Yasuo Mizuguchi and Masahiro Nakamura and Toshihiko Koga and Yoshida, {Shin Ichi}",
year = "1996",
month = "10",
day = "15",
doi = "10.1016/0378-1097(96)00346-1",
language = "English",
volume = "144",
pages = "103--108",
journal = "FEMS Microbiology Letters",
issn = "0378-1097",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis

AU - Taniguchi, Hatsumi

AU - Aramaki, Hironori

AU - Nikaido, Yoshihiko

AU - Mizuguchi, Yasuo

AU - Nakamura, Masahiro

AU - Koga, Toshihiko

AU - Yoshida, Shin Ichi

PY - 1996/10/15

Y1 - 1996/10/15

N2 - Using 39 clinical isolates of Mycobacterium tuberculosis strains with a broad range of susceptibility to rifampicin, we examined the relationship between the degree of resistance to rifampicin and mutational sites of the rpoB gene. All rifampicin-resistant strains had missense mutations. Twenty strains (95%) had a mutation in the cluster I region, which has also been reported in Escherichia coli [Jin and Gross (1988) J. Mol. Biol. 202, 45-58], and the remaining one strain had a mutation at codon 381 [Ala → Val] in the N-terminal region, which has not been reported in E. coli. Among 18 rifampicin-susceptible strains, two had a mutation in the cluster I region and the other three strains had a mutation in the cluster III region. The mutations at codons 513 (5%), 526 (33%) or 531 (43%) in the cluster I region led to high level resistance to rifampicin (50 μg ml-1 ≤ MIC). The mutations at the other sites, in the cluster III region (codons 679 or 687) and even in the cluster I region (codon 514, 521, or 533), showed low level (MIC = 12.5 μg ml-1) or no (MIC < 0.39 μg ml-1) resistance to rifampicin. These results suggest that mutations in the rpoB gene are, mostly, but not necessarily, associated with rifampicin resistance of M. tuberculosis, and the sites of mutations on the rpoB gene will affect the level of resistance to rifampicin.

AB - Using 39 clinical isolates of Mycobacterium tuberculosis strains with a broad range of susceptibility to rifampicin, we examined the relationship between the degree of resistance to rifampicin and mutational sites of the rpoB gene. All rifampicin-resistant strains had missense mutations. Twenty strains (95%) had a mutation in the cluster I region, which has also been reported in Escherichia coli [Jin and Gross (1988) J. Mol. Biol. 202, 45-58], and the remaining one strain had a mutation at codon 381 [Ala → Val] in the N-terminal region, which has not been reported in E. coli. Among 18 rifampicin-susceptible strains, two had a mutation in the cluster I region and the other three strains had a mutation in the cluster III region. The mutations at codons 513 (5%), 526 (33%) or 531 (43%) in the cluster I region led to high level resistance to rifampicin (50 μg ml-1 ≤ MIC). The mutations at the other sites, in the cluster III region (codons 679 or 687) and even in the cluster I region (codon 514, 521, or 533), showed low level (MIC = 12.5 μg ml-1) or no (MIC < 0.39 μg ml-1) resistance to rifampicin. These results suggest that mutations in the rpoB gene are, mostly, but not necessarily, associated with rifampicin resistance of M. tuberculosis, and the sites of mutations on the rpoB gene will affect the level of resistance to rifampicin.

UR - http://www.scopus.com/inward/record.url?scp=0030588059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030588059&partnerID=8YFLogxK

U2 - 10.1016/0378-1097(96)00346-1

DO - 10.1016/0378-1097(96)00346-1

M3 - Article

C2 - 8870258

AN - SCOPUS:0030588059

VL - 144

SP - 103

EP - 108

JO - FEMS Microbiology Letters

JF - FEMS Microbiology Letters

SN - 0378-1097

IS - 1

ER -